Maintenance Notice (12:30 AM - 5:30 AM August 24, 2025): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.198
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 14892-97-8 | Product Number: C3577
SCR7 Pyrazine
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- 6,7-Diphenyl-2-thioxo-2,3-dihydropteridin-4(8H)-one
- 6,7-Diphenyl-2-thiolumazine
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 10MG |
€105.00
|
1 | ≥60 |
|
| 50MG |
€338.00
|
2 | 19 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | C3577 |
Purity / Analysis Method 
|
>98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__8H__1__2N__4OS = 332.38 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Refrigerated (0-10°C) |
| Condition to Avoid | Heat Sensitive |
| CAS RN | 14892-97-8 |
| Reaxys Registry Number | 306520 |
| PubChem Substance ID | 468591173 |
| MDL Number | MFCD02167478 |
Specifications
| Appearance | White to Yellow to Green powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Melting point | 207.0 to 211.0 °C |
| Elemental analysis(Nitrogen) | 16.00 to 17.50 % |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 209 °C |
| Maximum Absorption Wavelength | 380 nm |
GHS
Related Laws:
Transport Information:
| HS Number | 2933998090 |
Application
CRISPR Genome Editing
SCR7 Pyrazine enhances CRISPR-mediated homology-directed repair (HDR) efficiency.
References
- Increasing the efficiency of CRISPR/Cas9-mediated precise genome editing of HSV-1 virus in human cells
Application
DNA Ligase Inhibitor: SCR7 Pyrazine
References
- CRISPR-Cas systems for editing, regulating and targeting genomes
- Increasing the efficiency of precise genome editing with CRISPR-Cas9 by inhibition of nonhomologous end joining
- Increasing the efficiency of homology-directed repair for CRISPR-Cas9-induced precise gene editing in mammalian cells
- An Inhibitor of Nonhomologous End-Joining Abrogates Double-Strand Break Repair and Impedes Cancer Progression
- SCR7 is neither a selective nor a potent inhibitor of human DNA ligase IV
- Synthesis and structure determination of SCR7, a DNA ligase inhibitor
- Autocyclized and oxidized forms of SCR7 induce cancer cell death by inhibiting nonhomologous DNA end joining in a Ligase IV dependent manner
- Water-soluble version of SCR7-pyrazine inhibits DNA repair and abrogates tumor cell proliferation
Documents
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.